Over the last 12 months, Thermo Fisher Scientific insiders reported no purchases and 6 sales totaling $20.9M across SEC Form 4 filings. 83% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Britt Lisa P.Sr. VP and Chief HR Officer · O | ▼ Sale | 5,850 | $580 | $3.4M | -28.4% | — |
| Aug 6, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 5,000 | $574.45 | $2.9M | -52% | plan · 9 tranches · indirect |
| Aug 6, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $574.47 | $5.7M | -7.5% | plan · 9 tranches |
| Aug 5, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 5,000 | $575.23 | $2.9M | -34.2% | plan · 11 tranches · indirect |
| Aug 5, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $575.23 | $5.8M | -7.5% | plan · 11 tranches |
| Jul 27, 2026 | Pettiti GianlucaPresident & COO · O | ▼ Sale | 400 | $565 | $226K | -1.6% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TMO feed.